Company intelligence / Profile preview

SPEF Venture

Paris, Île-de-France, France

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Seventure Partners, formerly known as SPEF Venture, is a leading European venture capital firm with a specialized focus on life sciences and digital technologies. Established in 1997 as a subsidiary of Natexis Banques Populaires (now Natixis), the firm rebranded in 2006 and has since become a pioneer in microbiome-related investments through its "Health for Life Capital" funds. The firm invests in innovative startups across biotechnology, medical devices, nutrition, and digital health, supporting companies from seed to growth stages. With headquarters in Paris, Seventure Partners manages over €1 billion in assets and maintains a diverse portfolio of international healthcare companies.

Industry: Investors

Partnerships

DanoneNovartisLesaffreTereosBel

Beyond the preview

Go deeper on SPEF Venture.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SPEF Venture.

Explore the full profile